AVMA news
Panel takes One Health approach to combating antimicrobial resistance
The executive director of the Presidential Advisory Council on Combating Antibiotic-Resistant Bacteria (PACCARB) briefed the AVMA House of Delegates…
AVMA news
Midwest Veterinary Supply sentenced to one year probation, pays $11M for misbranded drugs
Minnesota-based drug company Midwest Veterinary Supply recently was sentenced to one year of probation and agreed to pay more than $11 million in…
AVMA news
Zoetis receives $15.3M grant to improve livestock health in Africa
Zoetis announced in March that the company received a $15.3 million grant from the Bill & Melinda Gates Foundation to further develop and integrate…
AVMA news
USDA funds antimicrobial resistance dashboard research
The U.S. Department of Agriculture’s Animal and Plant Health Inspection Service has awarded more than $3.2 million to several universities to develop…
AVMA news
Multiple vaccine candidates in the works for African swine fever
For years, researchers have been working to develop a safe, effective, and commercially available vaccine for African swine fever as it continues to…
AVMA news
Bill seeks to strengthen US foreign animal disease response
Bipartisan legislation would increase funding, up to $265 million, for federal programs aimed at preventing and combating destructive foreign animal…
AVMA news
EPA confirms registration, safety of Seresto collar
The U.S. Environmental Protection Agency (EPA) confirmed the registration and affirmed the safety profile of the Seresto flea and tick collar after a…
AVMA news
A research facility ahead of its time
The state-of-the-art National Bio and Agro-Defense Facility, based in the nation’s heartland, is arguably the most advanced animal agriculture…
AVMA news
FDA creates guidance on informed consent for companion animal studies
The U.S. Food and Drug Administration (FDA) has announced draft guidance that will help animal owners who are considering having their companion…
AVMA news
Anti-doping program goes in effect for horse racing
The Horseracing Integrity and Safety Authority’s (HISA) Anti-Doping and Medication Control (ADMC) officially launched March 27. Under the ADMC…
policy
WVA position statement on use of horses for production of biologics and therapeutics
The AVMA endorses this position statement developed by the World Veterinary Association (WVA) on the use of horses for production of biologics and…
AVMA applauds passage of legislation to enhance the review process of new and generic animal drugs
In the latest government spending bill, Congress included and passed legislation that reauthorizes the Animal Drug User Fee Act (ADUFA) and the Animal…
AVMA news
Ditching the blame game: Effectively responding to medical errors
A session on veterinary medical errors at the 2023 Student AVMA (SAVMA) Symposium discussed what the most common errors are, the importance of…
AVMA news
Four veterinary scientists recognized with AVMA research awards
The AVMA honored Drs. Jim E. Riviere, Nicholas (Nick) Jeffery, Natasha Olby, and Boaz Arzi with 2023 AVMA Excellence Awards for contributions to…
AVMA news
FDA issues guidance on preventing drug carryover during manufacturing of animal food
The Food and Drug Administration issued guidance that compiles established practices that manufacturers of medicated animal food can use to prevent…
AVMA news
Addressing global inequities in access to essential medicines
The World Veterinary Association (WVA) and the World Small Animal Veterinary Association (WSAVA) are taking steps to improve the global availability…
AVMA news
USDA starts highly pathogenic avian influenza vaccine trials
In April, the U.S. Department of Agriculture (USDA) began testing the efficacy of four vaccines against highly pathogenic avian influenza (HPAI).…
AVMA news
FDA: Congress, not rule-making, likely route for CBD availability
With the cannabidiol products market continuing to grow and after reviewing published scientific literature and information submitted to a public…
AVMA news
AVMA webinars help veterinarians navigate opioid epidemic
Three new drug-related webinars are available on demand on AVMA Axon to help veterinarians meet their state’s continuing education (CE) requirements…
AVMA news
New law clarifies alternatives to animal testing for safety, efficacy of drugs
The recently passed FDA Modernization Act 2.0 authorizes the use of certain alternatives to animal testing, including cell-based assays and computer…
blog
AVMA endorses federal legislation to address illicit xylazine
The bill would equip law enforcement with additional tools to stop illegal xylazine trafficking while protecting veterinarians’ access to this…
blog
Compounding: How do new rules affect you?
The FDA says it will start phasing in inspectional activities in April for its new guidance on compounding from bulk drug substances. Here’s what…
AVMA news
FDA approves anemia drug for cats with chronic kidney disease
Varenzin-CA1 from Elanco is the first drug for the control of nonregenerative anemia associated with chronic kidney disease in cats to receive…
AVMA news
Monoclonal antibodies show promise as new therapy for veterinary patients
More than 100 monoclonal antibodies (mAb) designed to bind to specific target proteins are available for humans, including those intended to treat…
AVMA news
Canine osteoarthritis drug, Lyme disease bacteria vaccine receive approvals
Two recent drug approvals mean a novel treatment for the control of canine osteoarthritis (OA) pain and an oral vaccine against the wildlife spread of…